Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Igene Biotechnology, Inc. (IGNE)
Columbia, MD, US
Igene Biotechnology, Inc. is dedicated to the discovery, development, production, and commercialization of specialized ingredients for both human and animal nutrition. A key offering from the company is natural astaxanthin, a valuable nutrient utilized as a coloring agent for farmed salmon and trout. Additionally, it supplies a variety of ingredients and finished products to the nutraceutical and animal feed sectors. The company also extends its expertise through research and development services, which include enhancing microbial strains and skillfully developing and scaling up fermentation processes – from initial lab-based shake flasks to pilot plants and ultimately, commercial-sized fermentors. Furthermore, Igene provides analytical chemistry services for accurately identifying and quantifying carotenoids in food, feed, and animal tissues, notably offering verification to distinguish between wild and farm-raised salmonids. Established in 1981 and based in Columbia, Maryland, the company was originally named IGI Biotechnology, Inc. before officially adopting the name IGENE Biotechnology, Inc. in April 1986.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -98.75% | -98.33% | -99.99% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Agricultural Inputs: +9.5%-48.2% Q3'10: -100.0% (vs Q3'09)
-
EPS growth Agricultural Inputs: +23.0%+99.5% ★ Q3'10: -500.0% (vs Q3'09)
-
FCF margin FCF growth · Agricultural Inputs: +27.6%+21.0%
-
EBIT margin Agricultural Inputs: +9.7%+0.6%
-
ROIC Agricultural Inputs: +7.4%+0.9% Q3'10: -16.0% (vs Q3'09)
-
Share dilution Agricultural Inputs: +0.0%+722.2% Q3'10: +0.8% (vs Q3'09)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Inputs: 0.03×-7.98× Q3'10: -31.75× (vs Q3'09)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2010-10-20 | KIMELMAN MICHAEL | Director / Officer | S-Sale | D | Common Stock | 8,000,000 | 0.00 | 24.0K | 133,055,918 | — | ↗ |
| 2009-07-16 | KIMELMAN MICHAEL | Director / Officer | M-Exempt | A | Common Stock | 9,986,904 | 0.01 | 59.9K | 141,055,918 | — | ↗ |
| 2008-12-09 | KIMELMAN MICHAEL | Director / Officer | M-Exempt | A | COMMON STOCK | 120,717,844 | 0.01 | 1.51M | 120,968,948 | — | ↗ |
| 2008-12-03 | KEMPNER THOMAS L | Director / 10% Owner | J-Other | D | Convertible Debentures | 22,920,215 | 0.00 | — | 0 | — | ↗ |
| 2007-12-20 | KIMELMAN MICHAEL | Director / Officer | P-Purchase | A | Convertible Debentures | 200,000 | 0.08 | 16.0K | 200,000 | — | ↗ |
| 2007-12-20 | KEMPNER THOMAS L | Director / 10% Owner | S-Sale | D | Convertible Debentures | 0 | 0.04 | — | 13,854,919 | — | ↗ |
| 2007-12-01 | KIMELMAN MICHAEL | Director / Officer | E-ExpireShort | D | PROMISSORY NOTES | 804,568 | 0.10 | 80.5K | 0 | — | ↗ |
| 2007-06-05 | KEMPNER THOMAS L | Director / 10% Owner | W-Will | A | Common Stock | 182,526 | 0.00 | — | 650,618 | — | ↗ |
| 2007-04-11 | KEMPNER THOMAS L | Director / 10% Owner | W-Will | A | Common Stock | 81,120 | 0.00 | — | 468,092 | — | ↗ |
| 2007-02-15 | KEMPNER THOMAS L | Director / 10% Owner | P-Purchase | A | Convertible Debentures | 190,500 | 0.02 | 3.8K | 29,004,919 | — | ↗ |
| 2006-12-19 | KEMPNER THOMAS L | Director / 10% Owner | P-Purchase | A | Common Stock | 100,000 | 0.03 | 2.5K | 9,011,245 | — | ↗ |
| 2006-08-17 | KEMPNER THOMAS L | Director | P-Purchase | A | Common Stock | 10,000 | 0.04 | 400.00 | 120,000 | — | ↗ |
| 2006-06-28 | KEMPNER THOMAS L | Director | S-Sale | D | Common Stock | 200,000 | 0.04 | 8.0K | 8,961,245 | — | ↗ |
| 2006-06-15 | KEMPNER THOMAS L | Director / 10% Owner | P-Purchase | A | Common Stock | 500,000 | 0.04 | 20.0K | 9,161,245 | — | ↗ |
| 2006-03-23 | ABELES JOSEPH C | Director / 10% Owner | C-Conversion | A | 8% Convertible Preferred Stock | 14,750 | 0.00 | — | 2,128,294 | — | ↗ |
| 2005-09-12 | KEMPNER THOMAS L | Director / 10% Owner | J-Other | D | Convertible Debentures | 18,761,669 | 0.08 | 1.50M | 19,271,742 | — | ↗ |
| 2003-03-26 | KIMELMAN MICHAEL | Director | A-Award | A | Warrants | 11,000,000 | 0.06 | 660.0K | 16,325,672 | — | ↗ |
| 2002-02-28 | KEMPNER THOMAS L | Director / 10% Owner | W-Will | A | Common Stock | 162,240 | 0.00 | — | 162,240 | — | ↗ |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Joseph L. Downs | Chief Executive Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for IGNE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
